BR0315134A - Usos de il-21 e de um polipeptìdeo de il-21 - Google Patents
Usos de il-21 e de um polipeptìdeo de il-21Info
- Publication number
- BR0315134A BR0315134A BR0315134-4A BR0315134A BR0315134A BR 0315134 A BR0315134 A BR 0315134A BR 0315134 A BR0315134 A BR 0315134A BR 0315134 A BR0315134 A BR 0315134A
- Authority
- BR
- Brazil
- Prior art keywords
- diseases
- polypeptide
- allergic
- conditions
- eosinophils
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 206010027654 Allergic conditions Diseases 0.000 abstract 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 208000030852 Parasitic disease Diseases 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 230000006806 disease prevention Effects 0.000 abstract 1
- 210000003979 eosinophil Anatomy 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Otolaryngology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200201546 | 2002-10-11 | ||
| DKPA200201587 | 2002-10-16 | ||
| US41922502P | 2002-10-17 | 2002-10-17 | |
| PCT/DK2003/000691 WO2004032953A1 (en) | 2002-10-11 | 2003-10-13 | Treatment of allergic conditions by use of il 21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0315134A true BR0315134A (pt) | 2005-08-16 |
Family
ID=32096538
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0315134-4A BR0315134A (pt) | 2002-10-11 | 2003-10-13 | Usos de il-21 e de um polipeptìdeo de il-21 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1553970A1 (enExample) |
| JP (1) | JP2006525223A (enExample) |
| AU (1) | AU2003273758A1 (enExample) |
| BR (1) | BR0315134A (enExample) |
| CA (1) | CA2501807A1 (enExample) |
| MX (1) | MXPA05003729A (enExample) |
| PL (1) | PL376118A1 (enExample) |
| WO (1) | WO2004032953A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003302250B2 (en) | 2002-12-13 | 2009-08-27 | Zymogenetics, Inc. | IL-21 production in prokaryotic hosts |
| RU2006138704A (ru) * | 2004-05-19 | 2008-06-27 | Вайет (Us) | Модуляция производства иммуноглобулина и атопические расстройства |
| EP1937838B1 (en) | 2005-09-22 | 2011-03-09 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods of using il-21 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1082433A4 (en) * | 1998-05-29 | 2003-01-02 | Human Genome Sciences Inc | Interleukins 21 and 22 |
| CN102406937A (zh) * | 1999-03-09 | 2012-04-11 | 津莫吉尼蒂克斯公司 | 新的细胞因子zalpha11配体 |
| ES2349312T3 (es) * | 2000-07-27 | 2010-12-29 | Wyeth Llc | Uso de anticuerpos antagonistas del receptor de il-10 para inhibir la inducción por il-tif/il-21 de proteínas de fase aguda. |
| DK1432431T3 (en) * | 2001-10-04 | 2017-07-10 | Genetics Inst Llc | Methods and compositions for modulating interleukin-21 activity |
| AU2003230834A1 (en) * | 2002-04-09 | 2003-10-27 | Beth Israel Deaconess Medical Center, Inc. | Antagonists of il-21 and modulation of il-21-mediated t cell responses |
-
2003
- 2003-10-13 PL PL03376118A patent/PL376118A1/xx unknown
- 2003-10-13 BR BR0315134-4A patent/BR0315134A/pt not_active Application Discontinuation
- 2003-10-13 EP EP03757715A patent/EP1553970A1/en not_active Withdrawn
- 2003-10-13 WO PCT/DK2003/000691 patent/WO2004032953A1/en not_active Ceased
- 2003-10-13 AU AU2003273758A patent/AU2003273758A1/en not_active Abandoned
- 2003-10-13 CA CA002501807A patent/CA2501807A1/en not_active Abandoned
- 2003-10-13 MX MXPA05003729A patent/MXPA05003729A/es not_active Application Discontinuation
- 2003-10-13 JP JP2004542219A patent/JP2006525223A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| PL376118A1 (en) | 2005-12-12 |
| AU2003273758A1 (en) | 2004-05-04 |
| WO2004032953A1 (en) | 2004-04-22 |
| CA2501807A1 (en) | 2004-04-22 |
| JP2006525223A (ja) | 2006-11-09 |
| EP1553970A1 (en) | 2005-07-20 |
| MXPA05003729A (es) | 2005-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0312421A (pt) | Uso de inibidores de cept e opcionalmente inibidores hmg coa redutase e/ou agentes anti-hipertensivos | |
| NO20042298L (no) | Farmasoytiske preparater og deres anvendelser | |
| BR0313371A (pt) | Composto, uso de um composto e método de tratamento de doença | |
| MXPA05006670A (es) | Administracion de capsaicinoides. | |
| ATE362766T1 (de) | Apolipoprotein a-i agonisten sowie deren verwendung zur behandlung dislipidemischer erkrankungen | |
| BR0313041A (pt) | Compostos; composições farmacêuticas; método para o tratamento e/ou profilaxia de doenças que estão associadas à modulação dos receptores de cb1; e uso de compostos | |
| BR0214343A (pt) | Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1 | |
| ATE508114T1 (de) | Mit n-alkylhydroxamsäuren substituierte isoindolylverbindungen und deren pharmazeutische verwendung | |
| BR9917038A (pt) | Composto, composição farmacêutica, método de modulação da atividade receptora de quimocinas, método de tratamento ou prevenção de doenças inflamatórias, método de tratamento ou prevenção de asma e método de tratamento ou prevenção de disfunções inflamatórias | |
| WO2004006858A3 (en) | Compounds, compositions, and methods employing same | |
| NO20035025L (no) | Anvendelse av osteopontin for behandling og/eller for a hindre nevrologiske sykdommer, samt farmasoytisk sammensetning omfattende osteopontin eller en antagonist med osteopontinaktivitet. | |
| WO2003030934A3 (en) | Cpg formulations and related methods | |
| NO20050807L (no) | Farmasoytiske sammensetninger som innbefatter dekstrometorfan og kinidin for behandling av neurologiske forstyrrelser | |
| BRPI0517015A (pt) | compostos e composições como inibidores de atividade de receptor 1 de canabinóide | |
| PA8657201A1 (es) | Compuestos de 3h-oxazolo y 3h-tiazolo [4, 5-d] pirimidin-2-ona 3, 5-disustituida y 3, 5, 7 - trisustituida y profarmacos de los mismos | |
| BR0208636A (pt) | Agente terapêutico para doenças de artrìtides crÈnicas de doenças relacionadas com infncia | |
| BR0215622A (pt) | Inibidores da dpiv com base em glutaminila | |
| DOP2002000429A (es) | Imidazotriazinas | |
| BRPI0517481A (pt) | método para tratar, controlar ou evitar uma doença ou distúrbio parasìtico protozoário, e, composição farmacêutica | |
| HUP0100539A2 (hu) | D-vitamint és kálciumot tartalmazó gyógyászati készítmények és eljárás azok előállítására | |
| CY1113894T1 (el) | Φαρμακευτικη συνθεση που περιλαμβανει ροφλουμιλαστη και λεβοκετιριζινη | |
| SE0302488D0 (sv) | New combination | |
| WO2004100893A3 (en) | Methods for treatment of inflammatory diseases using ct-3 or analogs thereof | |
| DK1397681T3 (da) | Fremgangsmåde til identificering af midler til behandling af diabetes | |
| BR9916190A (pt) | Emprego de inibidores do canal kqt1 para a preparação de um medicamento para o tratamento de doenças, que são provocadas por helmintos e ectoparasitas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B11E | Dismissal acc. art. 34 of ipl - requirements for examination incomplete | ||
| B11T | Dismissal of application maintained [chapter 11.20 patent gazette] |